| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 56,890 | 28,416 | 18,651 | 24,829 | | Cost of Revenue | 10,847 | 10,762 | 9,511 | 9,415 | | | Gross Profit | 46,043 | 17,654 | 9,140 | 15,414 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (9,399) | 30,213 | 2,882 | 4,127 | | Non Recurring |
-
| 10,907 | (10,907) | (21,572) | | Others | 21,399 | 11,900 | 10,385 | (86,575) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,258 | (35,366) | 6,780 | 119,434 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (21,688) | 1 | 5 | 7 | | Earnings Before Interest And Taxes | 1,730 | (35,365) | 6,785 | 119,441 | | Interest Expense | (4,567) | 2,351 | 2,216 | 1,653 | | Income Before Tax | 6,297 | (37,716) | 4,569 | 117,788 | | Income Tax Expense | (38) | 200 | 1 | 475 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,335 | (37,916) | 4,568 | 117,313 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,335 | (37,916) | 4,568 | 117,313 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,335 | ($37,916) | $4,568 | $117,313 |
|
0.51% Nasdaq 
Income Statement
